Scientists at the Wuhan Institute of Virology in China have discovered a new lineage of a coronavirus in bats that can enter human cells in a similar fashion as SARS-CoV-2, the virus that causes Covid-19,

CoV-2, which can enter human cells using the same gateway as the highly contagious SAR-CoV-2 virus that causes COVID-19. However, researchers say the newly discovered germ is much less capable of rapi

Researchers at the Wuhan Institute of Virology in China said they discovered a new coronavirus in bats that enters cells using the same gateway as the virus that causes COVID-19.

Scientists from the Wuhan Institute of Virology in China have shared warnings of a new strain of Covid found in bats which has a fatality rate of 35%, amid fears of a new pandemic

Although definitions of gain-of-function differ, investigative reports leave no question researchers manipulated coronaviruses at Wuhan lab.

Researchers in China have discovered a new coronavirus in bats that they say has the potential to spread to humans, after the world was recently hit by the COVID-19 pandemic

CoV-2, was found in horseshoe bats in China and can bind to human cells in the same way as SARS-CoV-2, the virus behind Covid-19

China has cowed many of America’s elites, celebrities, athletes and politicians into silence. They fear losing jobs, contracts, investors, status and worse. Better to stay silent.

One of Trump’s biggest complaints was that the agency was too slow to alert the world of an emerging health threat in China and to move to contain its spread. Local newspapers had been reporting that a mysterious illness was spreading around Wuhan as early as November 17, 2019, a fact backed up by genetic analysis.

The US withdrawal will not officially happen until January 2026, so there will be months of uncertainty over budgets and strategic direction at the near-80-year-old agency. Set up by the United Nations, the organization’s goals include expanding universal health coverage and coordinating the world’s response to health emergencies.

Moderna Inc. rose by as much as 6.6%, while Novavax Inc. climbed 7.8%. American depositary receipts of BioNTech SE, the partner of Pfizer in the development of the Covid vaccine, surged by 5.1%, and Pfizer itself saw an uptick of 2.6%.